Shortages of vital drugs, particularly cancer-fighting medication, have raised concerns in the US, where regulators often have to race to try to find replacements.
A recent report by the Federal Drug Administration (FDA) found that the number of important treatments that are difficult or impossible to find nearly tripled from 61 to 178 between 2005 and last year.
Most of the rare medications are for hospital use, including sterile injections, intravenous treatments, anesthetics and antibiotics. The products include both name-brand and generic drugs.
“FDA hears from patients and also from healthcare -professionals and organizations about the terrible impact the shortages have had,” spokeswoman Shelly Burgess said. “We continue to do all we can under our current authority to address shortages when they occur.”
However, the FDA’s efforts are hindered because it cannot force private pharmaceutical companies to produce certain drugs or even require them to notify the agency when they plan to discontinue one, Burgess said.
Last year, it was able to avert 38 shortages, mainly by persuading other manufacturers to produce the drugs or helping to resolve production issues.
However, a survey of 820 -hospitals carried out in June by the American Hospital Association found that almost all had run out of an important drug over the past six months.
Eighty percent said they had to delay patient treatments because of drug scarcity, and 70 percent said they administered less effective treatments.
“We really need to take a very careful look at what is going on. I have never seen anything like this and I have been a pharmacist for over 40 years,” said Mike Cohen, a pharmacist at the non-profit Safe Medical Practices.
The group recently surveyed 1,800 health professionals and found that a third of doctors and a fifth of pharmacists were aware of adverse reactions in their patients — including deaths — because of drug shortages.
Cynthia Reilly of the American Society of Health System Pharmacists said the “dramatic increase” in shortages is in part due to “quality issues.”
“In a lot of instances, the manufacturer is either having problems with the production lines or perhaps they found particular products in vials, so they have to do a recall,” she said.
Reilly fears the shortages will worsen as the pharmaceutical industry continues to consolidate, and as more companies stop producing generic drugs because they are less profitable.
“A few years ago, five companies were making a similar product. Now there is only one or two ... There are not a lot of companies to fill the gap,” she said.
She and other advocates believe new legislation to allow the FDA to force companies to alert it six months in advance of closing a production line would be helpful, because it would give the agency more time to find a substitute.
Two bills with broad support are currently under discussion in Congress.
Another problem is the so-called “gray market,” whereby distributors scoop up rare drugs and then charge hospitals exorbitant rates for them. Some drugs can fetch up to 1,000 times the normal price.
“We tell our members to contact their state attorney general. Unfortunately there is opportunity for unscrupulous behavior,” Reilly said.
‘CROSSING THE LINE’: China’s embassy in Seoul criticized US Forces Korea Commander General Xavier Brunson, asking if his ‘hostile’ remarks were authorized by Washington South Korea and the US are in talks over recent public remarks by the commander of US Forces Korea, Seoul’s presidential office said yesterday, after the comments drew sharp criticism from China. In a recent podcast interview, US Forces Korea Commander General Xavier Brunson described South Korea as “the dagger in the heart of Asia” from China’s east coast, prompting the Chinese embassy in Seoul to say that he had “truly crossed the line.” The interview came amid growing speculation that Washington might seek to expand the role of US Forces Korea in countering the growing regional influence of China, a key
SEEKING ORDER: Rodrigo Paz said that ‘anyone who wants to destroy the nation will have to deal with this president and the full force of the constitution’ Bolivian President Rodrigo Paz on Wednesday said that the nation was at a “breaking point” after nearly a month of protests that have caused shortages of food, fuel and medicine. Paz, who took office six months ago amid the worst economic crisis there in four decades, is battling a groundswell of fury over his policies. The political capital, La Paz, has been besieged by low-income workers and members of the indigenous majority calling for his resignation. “The country needs order and is reaching breaking point,” the 58-year-old said at a public event in La Paz, renewing his appeal for dialogue. On Tuesday, the Bolivian
Forecasters in Europe yesterday warned of exceptional heat as record temperatures driven by a “heat dome” push temperatures well above seasonal norms across the continent. The surge follows a record-breaking Monday, with France logging its hottest day in the month of May on record, its weather agency said, and the UK also posting unprecedented highs. A so-called “heat dome” of warm air from northern Africa trapped under a high-pressure system over western Europe is behind the high temperatures not usually seen until high summer. Restrictions on outdoor work were imposed in parts of Italy, beaches in southwest France filled earlier than usual and
Australian researchers have trained lab-grown brain cells on a silicon computer chip to play the 1990s shooter game Doom and said they are just scratching the surface of what the neurons could be capable of doing. It is the science-fiction work of biotech boffins at Cortical Labs, who researched and developed the technology that harnesses the workings of the brain’s networking system. Each so-called “biological computer” contains about 200,000 living human brain cells, grown from stem cells that were harvested from blood donations. Having mastered the simple computer game Pong, where a paddle is moved up and down to send a ball
RSS